Cargando…
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
Olorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections e...
Autores principales: | Georgacopoulos, Ourania, Nunnally, Natalie S., Ransom, Eric M., Law, Derek, Birch, Mike, Lockhart, Shawn R., Berkow, Elizabeth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150786/ https://www.ncbi.nlm.nih.gov/pubmed/34065811 http://dx.doi.org/10.3390/jof7050378 |
Ejemplares similares
-
In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans
por: Georgacopoulos, Ourania, et al.
Publicado: (2023) -
Review of the Novel Investigational Antifungal Olorofim
por: Wiederhold, Nathan P.
Publicado: (2020) -
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021) -
Anticancer and Antifungal Compounds from Aspergillus, Penicillium and Other Filamentous Fungi
por: Bladt, Tanja Thorskov, et al.
Publicado: (2013) -
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance
por: Buil, Jochem B., et al.
Publicado: (2022)